
Symbotic Inc. (SYM) reported mixed Q3 2025 results, with revenue up 26% to $592 million but an unexpected loss per share of $0.05, missing estimates. Following a significant stock surge of over 212% in six months, UBS downgraded SYM from Neutral to Sell, citing high equity valuation at 10 times estimated 2027 sales and concerns over growth acceleration or new business beyond its primary customer, Walmart, despite raising its price target to $35.00. This downgrade, coupled with a recent insider stock sale by VP Maria G. Freve, highlights increasing scrutiny on the company's valuation and growth prospects.
Symbotic Inc. (SYM) reported mixed third-quarter 2025 results, with revenue increasing 26% year-over-year to $592 million, yet posting an unexpected loss per share of $0.05 against an anticipated $0.05 profit. This financial performance follows a substantial stock surge, with shares gaining over 212% in the past six months and 189% year-to-date, reaching a $41.85 billion valuation. Despite this strong market performance, UBS downgraded Symbotic from Neutral to Sell, citing high equity valuation at 10 times estimated 2027 sales. While UBS raised its price target to $35.00 from $27.00, the downgrade underscores significant concerns regarding the stock's current trading level of $70.72. InvestingPro analysis, however, suggests shares are trading near their Fair Value, indicating a divergence in valuation perspectives. A key apprehension highlighted by UBS is the lack of clear signs for growth acceleration or new business beyond Symbotic's primary customer, Walmart. This concern is compounded by a recent insider transaction, where VP Maria G. Freve sold 482 shares for $33,004 following the exercise of options, potentially signaling profit-taking after the stock's considerable run-up.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.15
Ticker Sentiment